BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31876753)

  • 1. Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines.
    Chen H; Yao X; Li T; Lam CW; Zhang H; Wang J; Zhang W; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Dec; 98(52):e18552. PubMed ID: 31876753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
    Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
    J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines.
    Wang X; Liu Z; Sui X; Wu Q; Wang J; Xu C
    Phytomedicine; 2019 Jun; 59():152787. PubMed ID: 31005810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound Kushen injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 37 RCTs following the PRISMA guidelines.
    Chen H; Yao X; Li T; Lam CW; Zhang R; Zhang H; Wang J; Zhang W; Leung EL; Wu Q
    J Cancer; 2020; 11(7):1883-1898. PubMed ID: 32194799
    [No Abstract]   [Full Text] [Related]  

  • 6. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
    Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
    Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
    Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
    Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Tan X; Liang X; Xi J; Guo S; Meng M; Chen X; Li Y
    Medicine (Baltimore); 2021 Sep; 100(36):e27161. PubMed ID: 34516509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews.
    Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ
    J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial.
    Wang XQ; Liu J; Lin HS; Hou W
    Trials; 2016 Mar; 17(1):124. PubMed ID: 26956875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
    Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
    J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cinobufacini injection combined with vinorelbine and cisplatin regimen chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Li Q; Liang RL; Yu QR; Tian DQ; Zhao LN; Wang WW; Xiao H; Yong XJ; Peng XD
    Medicine (Baltimore); 2020 Jul; 99(31):e21539. PubMed ID: 32756206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
    Santos FN; de Castria TB; Cruz MR; Riera R
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010463. PubMed ID: 26482542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC: A protocol for systematic review and network meta-analysis.
    Li J; Zhu GH; Liu TT; Xu BW; Li J
    Medicine (Baltimore); 2020 Jul; 99(28):e21041. PubMed ID: 32664114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines.
    Xiao Z; Wang C; Sun Y; Li N; Li J; Chen L; Yao X; Ding J; Ma H
    Medicine (Baltimore); 2016 Nov; 95(44):e5210. PubMed ID: 27858864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
    Feng F; Huang J; Wang Z; Zhang J; Han D; Wu Q; He H; Zhou X
    BMC Complement Med Ther; 2020 Jan; 20(1):3. PubMed ID: 32020869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.
    Chen Y; Zhang C; Pan C; Yang Y; Liu J; Lv J; Pan G
    Medicine (Baltimore); 2021 Nov; 100(44):e27524. PubMed ID: 34871214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive effect of compound Kushen injection for cancer: An overview of systematic reviews.
    Li C; Niu D; Zhu R; Yan X; Qu H; Zhang Y; Zheng Y
    J Ethnopharmacol; 2023 Dec; 317():116778. PubMed ID: 37328082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review.
    Dong J; Su SY; Wang MY; Zhan Z
    J Exp Clin Cancer Res; 2010 Oct; 29(1):137. PubMed ID: 20969765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.